Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
09/05/2000 | US6114386 1-((substituted)alkylcarbonylamino),2-(hydroxyl or amino)-substituted benzene compounds of given formula; treating and preventing bacterial or trypanosomal infection using the inhibitor |
09/05/2000 | US6114364 2-((substituted)alkyl(thio, sulfonyl, or sulfoxy)methyl), 3-(carboxyl or aliphatic hydrocarbonyl)cyclopentan-1-one derivatives, except cystacyclin; use as neuron differentiation accelerator |
09/05/2000 | US6114343 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-flurocytosin-1-yl)-1,3-oxathiolane |
09/05/2000 | US6114342 2-(O-[pyrimidin-4-yl]methylenoxy)phenylacetic acid derivatives and their use for controlling harmful fungi and animal pests |
09/05/2000 | US6114339 Derivatives of pyrido [2,3-D] and [3,2-D] pyrimidine method of using these derivatives |
08/31/2000 | WO2000050431A1 Platinum (ii) compounds |
08/31/2000 | WO2000040558A8 Aspartic protease inhibitors |
08/31/2000 | WO2000001375A3 Calcium channel blockers |
08/31/2000 | DE19908567A1 New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases |
08/31/2000 | CA2364712A1 Platinum (ii) compounds |
08/30/2000 | EP1031570A1 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency |
08/30/2000 | EP1031563A1 Sulfonyl derivatives |
08/30/2000 | EP1030846A1 Method for producing ar(alk)yluraciles, novel corresponding intermediate products and method for producing said intermediate products |
08/30/2000 | EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
08/30/2000 | EP1030843A1 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
08/30/2000 | EP1030840A1 Cyclic amine derivatives and their use as drugs |
08/30/2000 | EP0888297B1 N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds |
08/30/2000 | CN1265096A Hydrazine derivatives |
08/29/2000 | US6111102 Processes for preparing sulfonylureas |
08/29/2000 | US6110938 1-(arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics |
08/29/2000 | US6110925 Antibiotic for methicillin resistant bacteria |
08/29/2000 | US6110924 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
08/29/2000 | US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
08/29/2000 | US6110920 Treatment of cardiovascular disorders and impotency |
08/29/2000 | US6110870 N-cyanoaryl-nitrogen heterocycles |
08/29/2000 | CA2040068C 1-{[0-(cyclopropylcarbonyl) phenyl]sulfamoyl}-3-(4,6-dimethoxy-2-pyrimidinyl) urea and method for the preparation thereof |
08/24/2000 | WO2000049016A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds |
08/24/2000 | WO2000049014A1 Process for the production of tert-butyl (e)-(6-[2- [4-(4-fluorophenyl) -6-isopropyl-2-[ methyl (methylsulfonyl) amino] pyrimidin-5-yl] vinyl](4r, 6s)-2,2-dimethyl [1,3]dioxan-4-yl) acetate |
08/24/2000 | WO2000049004A1 Process for the preparation of 6-(perfluoroalkyl) uracil compounds from urea compounds |
08/24/2000 | WO2000049003A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds |
08/24/2000 | WO2000049002A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils |
08/24/2000 | WO2000049001A2 Phenoxy-, phenylthio-, phenylamino-, benzyloxy-, benzylthio- or benzylaminopyrimidine insectidices and acaricides |
08/24/2000 | WO2000048996A2 β-ALANINE DERIVATIVES |
08/24/2000 | WO2000048994A1 Thioamide derivatives |
08/24/2000 | WO2000048447A2 Composition for treatment of external secretion disorders except hypolacrimation |
08/24/2000 | CA2371824A1 .beta.-alanine derivatives |
08/24/2000 | CA2364281A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils |
08/24/2000 | CA2363000A1 Process for the preparation of 6-(perfluoroalkyl) uracil compounds from urea compounds |
08/24/2000 | CA2362996A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds |
08/24/2000 | CA2362990A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds |
08/24/2000 | CA2328877A1 Composition for treatment of external secretion disorders except hypolacrimation |
08/23/2000 | EP1029909A1 Organic electroluminescence device and phenylenediamine derivative |
08/23/2000 | EP1029853A1 Heteroaromatic bicyclic derivatives useful as anticancer agents |
08/23/2000 | EP1029851A1 Piperazine compounds and medicinal use thereof |
08/23/2000 | EP1029842A2 Polyhaloalkyl ether derivatives as well as liquid crystal compositions and liquid crystal display elements containing them |
08/23/2000 | EP1028955A1 Pyrimidinone compounds and pharmaceutical compositions containing them |
08/23/2000 | EP1028950A1 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents |
08/23/2000 | EP1028949A1 Carbamoylphenylsulfonyl ureas, method for their production and their application as herbicides and plant growth regulators |
08/23/2000 | EP1028944A1 Fluorinated naphthalene derivatives and their use in liquid crystal mixtures |
08/23/2000 | EP0842146B1 Oximether and acrylic acid derivatives and their use as fungicides |
08/23/2000 | EP0765926B1 Liquid-crystal composition and liquid-crystal display device |
08/23/2000 | EP0674642B1 Pyrazolopyrimidines as crf antagonists |
08/23/2000 | CN1264382A Novel compounds |
08/23/2000 | CN1264375A Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
08/22/2000 | US6107485 In one step, by reacting n-substituted amidine (or its hydrochloride salt) with a beta-keto ester in the presence of a base under conditions of high pressure |
08/22/2000 | US6107301 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
08/22/2000 | US6107300 Arylamino fused pyrimidines |
08/22/2000 | US6107299 Insecticides; miticides |
08/22/2000 | US6107298 Methods for prevention and treatment of Tourette's syndrome and schizophrenia |
08/22/2000 | US6107297 2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists |
08/22/2000 | US6107252 Substituted phenyl uracils and their use as herbicides |
08/22/2000 | US6107066 Coumarin derivative-n-linked lipid used as a fluorophore capable of undergoing energy transfer |
08/22/2000 | US6106908 Liquid crystalline (E, E)-butadiene compounds and mixtures and devices containing such compounds |
08/22/2000 | CA2187409C Stable crystalline tetrahydrofolic acid salts |
08/17/2000 | WO2000047565A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
08/17/2000 | WO2000047564A1 Novel guanidine derivatives as inhibitors of cell adhesion |
08/17/2000 | WO2000047554A2 INHIBITORS OF FACTOR Xa |
08/17/2000 | WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
08/17/2000 | WO2000047539A1 Fluorinating agent, process for producing the same, and use thereof |
08/17/2000 | WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors |
08/17/2000 | WO2000024358A3 Synthesis and uses of thiopentone enantiomers |
08/17/2000 | WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
08/17/2000 | CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa |
08/17/2000 | CA2361428A1 Inhibitors of factor xa |
08/16/2000 | EP1028114A1 Novel guanidine derivatives as inhibitors of cell adhesion |
08/16/2000 | EP1028112A1 Phenylglycinolamides linked by a hetero-atom with antiatherosclerotic agents |
08/16/2000 | EP1028111A1 Amide derivatives or salts thereof |
08/16/2000 | EP1027713A1 Nonaqueous electrolyte for electrical storage devices |
08/16/2000 | EP1027403A2 5-arylindane derivatives and ferroelectric liquid crystal mixture containing same |
08/16/2000 | EP1027339A1 Method and reagents for n-alkylating ureides |
08/16/2000 | EP1027338A2 New carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists |
08/16/2000 | EP0738259B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
08/16/2000 | CN1055469C Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds, its preparing method and use |
08/16/2000 | CN1055468C Alkylaminoindane compounds process for preparing them and pharmaceutical compositions containing them,and use |
08/16/2000 | CN1055461C Aryl acetic acid derivatives and use as germicide |
08/16/2000 | CN1055375C Solid composition of agricultural chemical product and method for its production |
08/15/2000 | US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent |
08/15/2000 | US6103898 Reacting acyclic urea derivative with a diketone, subsequent catalytic hydrogenation to form cyclized polar aprotic solvent |
08/15/2000 | US6103738 Quinoline and quinazoline compounds useful in therapy |
08/15/2000 | US6103737 Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists |
08/15/2000 | US6103732 Endothelin receptor inhibitors; hypotensive agents, cardiotonic agents; acute myocardial infarct, pulmonary hypertension, raynaud's syndrome, atherosclerosis; asthma; cardiovascular disorders |
08/15/2000 | US6103730 Amine substituted compounds |
08/15/2000 | US6103729 Cathecol derivatives and a method for the preparation thereof and a pharmaceutical composition containing the same |
08/15/2000 | US6103728 Modulating tyrosine signal transduction to prevent and treat cell proliferative disorders or cell differentiation disorders by inhibiting one or more abnormal tyrosine kinase activities; anticarcinogenic,-tumor, proliferative agents |
08/15/2000 | US6103727 Pyrimidine derivatives and methods of making and using these derivatives |
08/15/2000 | US6103719 Neurokinin-a- or neurokinin-b tachnkinin antagonistic properties; substance p antagonism; respiratory, gastrointestinal, nervous system, skin disorders; |
08/15/2000 | US6103717 Strong fungicides; bactericides; microbiocides; nonphytotoxic; crops, cereals, fruits, vegetables |
08/15/2000 | CA2202280C Sugar modified nucleosides and their use for synthesis of oligonucleotides |
08/15/2000 | CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid |
08/10/2000 | WO2000046214A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |